5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (Q44413951)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 16, 2003

Language	Label	Description	Also known as
English	5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens	scientific article published on May 16, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (English)

1 reference

Europe PubMed Central

2 December 2017

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (English)

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

0 references

nucleus accumbens

1 reference

based on heuristic

inferred from title

author name string

Toshihide Kuroki

1

1 reference

Europe PubMed Central

2 December 2017

Junji Ichikawa

3

1 reference

Europe PubMed Central

2 December 2017

Herbert Y. Meltzer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12711095

27 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

16 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711095

27 December 2023

number of pages

6

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0006899303025162?httpAccept=text/xml

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

https://api.elsevier.com/content/article/PII:S0006899303025162?httpAccept=text/plain

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

1 reference

Europe PubMed Central

2 December 2017

972

1 reference

Europe PubMed Central

2 December 2017

1-2

1 reference

Europe PubMed Central

2 December 2017

216-221

1 reference

Europe PubMed Central

2 December 2017

5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902516-2

7 January 2021

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors

36

1 reference

10.1016/S0006-8993(03)02516-2

https://api.crossref.org/works/10.1016/S0006-8993(03)02516-2

27 December 2023

Identifiers

10.1016/S0006-8993(03)02516-2

1 reference

Europe PubMed Central

2 December 2017

release_fx2cmhwxkjhorovjg5liqblu7m

1 reference

https://api.fatcat.wiki/v0/release/fx2cmhwxkjhorovjg5liqblu7m

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44413951&oldid=2037943977"